Hepatic lipase gene polymorphisms influence plasma HDL levels: Results from Finnish EARS participants

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 10, 1997, Pages 1879-1884

  Murtomäki, Sanna ^a   Tahvanainen, Esa ^a   Antikainen, Marjatta ^a,b   Tiret, Laurence ^c   Nicaud, Viviane ^c   Jansen, Hans ^d   Ehnholm, Christian ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HÔPITAL BROUSSAIS   (France)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Atherosclerosis; European Atherosclerosis Research Study; Hepatic lipase; High density lipoproteins; Polymorphism

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CORONARY RISK; FINLAND; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL;

EID: 0031442316     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.10.1879     Document Type: Article

References (28)

1. Ehnholm C, Kuusi T. Preparation, characterization, and measurement of hepatic lipase. Methods Enzymol. 1986;129:716-738.
2. Shafi S, Brady SE, Bensadoun A, Havel RJ. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J Lipid Res. 1994;35:709-720.
3. Clay MA, Newnham HH, Forte TM, Barter PJ. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apoA-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta. 1992;1124:52-58.
4. Atherosclerosis X, Proceedings of the 10th International Symposium on Atherosclerosis. In: Woodford FP, Davignon J, Sniderman, eds. Amsterdam, Netherlands. Elsevier Science; 1995:731-735.
5. Bensadoun A, Berryman DE. Genetics and molecular biology of hepatic lipase. Curr Opin Lipidol. 1996;7:77-81.
6. Verhoeven AJM, Jansen H. Hepatic lipase mRNA is expressed in rat and human steroidogenic organs. Biochim Biophys Acta. 1994;1211:121-124.
7. Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol. 1995;6:291-305.
8. Hegele RA, Tu L, Connelly PW. Human hepatic lipase mutations and polymorphisms. Hum Mutat. 1992;1:320-324.
9. Hegele RA, Little JA, Vezina C, Maguire G, Tu L, Wolever T, Jenkins DJA, Connelly PW. Hepatic lipase deficiency: clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb. 1993;13:720-728.
10. Homanics GE, de Suva HV, Osada J, Zhang SH, Wong H, Borensztajn J, Maeda N. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J Biol Chem. 1995;270:2974-2980.
11. Knudsen P, Antikainen M, Ehnholm S, Uusi-Oukari M, Tenkanen H, Lahdenperä S, Kahri J, Tilly-Kiesi M, Bensadoun A, Taskinen M-R, Ehnholm C. A compound heterozygote for hepatic lipase gene mutations Leu334-Phe and Thr383-Met: correlation between hepatic lipase activity and phenotypic expression. J Lipid Res. 1996;37:825-834.
12. Knudsen P, Antikainen M, Uusi-Oukari M, Ehnholm S, Lahdenperä S, Bensadoun A, Funke H, Wiebusch H, Assmann G, Taskinen M-R, Ehnholm C. Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis. 1996;128:165-174.
13. Brand K, Dugi KA, Brunzell JD, Kevin DN, Santamarina-Fojo S. A novel A-G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J Lipid Res. 1996;37:1213-1223.
14. Blades B, Vega GL, Grundy SM. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb. 1993;13:1227-1235.
15. Kuusi T, Ehnholm C, Viikari J, Härkönen R, Vartiainen E, Puska P, Taskinen M-R. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteincmia. J Lipid Res. 1989;30:1117-1126.
16. Takagi A, Ikeda Y, Mori A, Ashida Y, Yamamoto A. Identification of a BstNI polymorphism in exon 9 of the human hepatic triglyceride lipase gene. Mol Cell Probes. 1996;10:313-314.
17. Mori A, Takagi A, Ikeda Y, Ashida Y, Yamamoto A. An Avail polymorphism in exon 5 of the human hepatic triglyceride lipase gene. Mol Cell Probes. 1996;10:309-311.
18. Jansen H, Verhoeven AJM, Weeks L, Kastelein JJP, Halley DJJ, van den Ouweland A, Jukema JW, Seidell JC, Birkenhager JC. A common C to T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery in coronary artery disease patients. ATVB 1997. In press.
19. Breckenridge WC, Little JA, Alaupovic P, Wang CS, Kuksis A, Kakis G, Lindgren F, Gardiner G. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis. 1982;45:161-179.
20. The EARS Group. The European Atherosclerosis Research Study (EARS): design and objectives. Int J Epidemiol. 1994;23:465-471.
21. Tiret L, Nicaud V, Ehnholm C, Havekes L, Menzel HJ, Ducimetiére P, Cambien F. Inference of the strength of genotype-disease association from studies comparing offspring with and without parental history of disease. Ann Hum Genet. 1993;57:141-149.
22. Tiret L, de Knijff P, Menzel H-J, Ehnholm C, Nicaud V, Havekes LM, for the EARS group. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations: the EARS study. Arterioscler Thromb. 1994;14:1617-1624.
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
24. Syvänen AC, Sajantila A, Lukka M. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am J Hum Genet. 1993;52:46-59.
25. MacLean CJ, Morton NE. Estimation of MYRIAD haplotype frequencies. Genet Epidermal. 1985;2:263-272.
26. Tiret L, Amouyel P, Rakotovao R, Ducimetiére P. Testing for association between disease and linked marker loci: a log-linear model analysis. Am J Hum Genet. 1991;48:926-934.
27. Perkins KA. Family history of coronary heart disease: is it an independent risk factor? Am J Epidemiol. 1989;124:182-194.
28. Myers RH, Kiely DK, Cupples LA, Kannel WB. Parental history is an independent risk factor for coronary artery disease: the Framingham study. Am Heart J. 1990;120:963-969.